Edition:
United Kingdom

MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

20.30USD
16 Aug 2018
Change (% chg)

$0.47 (+2.37%)
Prev Close
$19.83
Open
$19.97
Day's High
$20.46
Day's Low
$19.74
Volume
98,423
Avg. Vol
108,846
52-wk High
$32.57
52-wk Low
$15.39

Chart for

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology... (more)

Overall

Beta: 2.78
Market Cap(Mil.): $659.43
Shares Outstanding(Mil.): 36.80
Dividend: --
Yield (%): --

Financials

  MGNX.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -4.18 -- --
ROI: -49.45 1.78 14.61
ROE: -52.35 3.28 16.33

BRIEF-MacroGenics Posts Qtrly Net Loss Per Common Share Of $1.34

* MACROGENICS PROVIDES UPDATE ON CORPORATE PROGRESS AND 1ST QUARTER 2018 FINANCIAL RESULTS

07 May 2018

BRIEF-Macrogenics Inc Prices Of Public Offering

* MACROGENICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

28 Mar 2018

BRIEF-Macrogenics Announces Proposed Public Offering Of Common Stock

* MACROGENICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

26 Mar 2018

BRIEF-Macrogenics Provides Update On Corporate Progress And 2017 Financial Results

* MACROGENICS PROVIDES UPDATE ON CORPORATE PROGRESS AND 2017 FINANCIAL RESULTS

27 Feb 2018

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF239.95 +0.75
Roche Holding Ltd. (RO.S) CHF243.20 +0.20
Amgen, Inc. (AMGN.OQ) $197.64 +1.20
Xencor Inc (XNCR.OQ) $39.72 -0.32

Earnings vs. Estimates